SCHEMBL284764

SCHEMBL284764

CC(C)(C)OC(=O)NCCNC(=O)c1cccc(C(=O)NCCNC(=O)OC(C)(C)C)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.55
NQO2 P16083 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
KMT2A Q03164 2/20 0.49
GAA P10253 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MALT1 Q9UDY8 1/20 0.48
TP53BP1 Q12888 4/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
POLB P06746 1/20 0.48
ACACB O00763 1/20 0.47
ACACA Q13085 1/20 0.47
BCHE P06276 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL264483 0.94 SMN1; SMN2 (0.50) SMN1; SMN2NQO2L3MBTL1KMT2AGAA
SCHEMBL5663889 0.94 SMN1; SMN2 (0.50) SMN1; SMN2NQO2L3MBTL1KMT2AGAA
SCHEMBL16152246 0.94 SMN1; SMN2 (0.60) SMN1; SMN2NQO2L3MBTL1KMT2AGAA
SCHEMBL265731 0.93 SMN1; SMN2 (0.49) SMN1; SMN2NQO2L3MBTL1KMT2AGAA
SCHEMBL284884 0.93 SMN1; SMN2 (0.59) SMN1; SMN2TP53BP1LMNA
SCHEMBL14679371 0.91 NPC1 (0.57) SMN1; SMN2KMT2AGAAALDH1A1MEN1
SCHEMBL10123873 0.90 ALDH1A1 (0.47) SMN1; SMN2NQO2L3MBTL1KMT2AHSD17B10
SCHEMBL5663105 0.90 TP53BP1 (0.62) SMN1; SMN2NQO2L3MBTL1KMT2AMALT1
SCHEMBL1754810 0.89 POLB (0.58) SMN1; SMN2GAAMALT1POLBBCHE
SCHEMBL16151786 0.89 SMN1; SMN2 (0.71) SMN1; SMN2L3MBTL1KMT2AGAATP53BP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580749-B2 Dyes and labeled molecules BIOTIUM, INC. (US) 2017-02-28 US disclosed
CN-102942566-B Dimerization and trimerization nucleic acid dye and relevant system and method BIOTIUM INC. (US) 2016-04-20 CN disclosed
CN-101142326-B Dimeric and trimeric nucleic acid dyes and related systems and methods BIOTIUM, INC. (US) 2015-09-30 CN disclosed
US-9102835-B2 Methods of using dyes in association with nucleic acid staining or detection and associated technology BIOTIUM, INC. (US) 2015-08-11 US disclosed
US-8753814-B2 Methods of using dyes in association with nucleic acid staining or detection and associated technology BIOTIUM, INC. (US) 2014-06-17 US disclosed
US-20140106349-A1 Dyes and Labeled Molecules ALLELOGIC BIOSCIENCES CORPORATION (US) 2014-04-17 US disclosed
US-20140073058-A1 Methods of Using Dyes in Association with Nucleic Acid Staining or Detection and Associated Technology BIOTIUM, INC. (US) 2014-03-13 US disclosed
US-8530195-B2 Dyes and labeled molecules BIOTIUM, INC. (US) 2013-09-10 US disclosed
US-20130167309-A1 METHODS OF USING DYES IN ASSOCIATION WITH NUCLEIC ACID STAINING OR DETECTION AND ASSOCIATED TECHNOLOGY BIOTIUM, INC. (US) 2013-07-04 US disclosed
EP-2428586-B1 Dimeric nucleic acid dyes, and associated systems and methods BIOTIUM INC (US) 2013-05-08 EP disclosed
US-20100317016-A1 DYES AND LABELED MOLECULES BIOTIUM, INC. (US) 2010-12-16 US disclosed
US-7803943-B2 Methods of using dyes in association with nucleic acid staining or detection and associated technology BIOTIUM, INC. (US) 2010-09-28 US disclosed
US-7776567-B2 Dimeric and trimeric nucleic acid dyes, and associated systems and methods BIOTIUM, INC. (US) 2010-08-17 US disclosed
US-20100009454-A1 METHODS OF USING DYES IN ASSOCIATION WITH NUCLEIC ACID STAINING OR DETECTION AND ASSOCIATED TECHNOLOGY BIOTIUM, INC. 2010-01-14 US disclosed
US-7601498-B2 Methods of using dyes in association with nucleic acid staining or detection and associated technology BIOTIUM, INC. (US) 2009-10-13 US disclosed
EP-1863933-A4 DIMERIC AND TRIMERIC NUCLEIC ACID DYES, AND ASSOCIATED SYSTEMS AND METHODS BIOTIUM INC (US) 2009-04-08 EP disclosed
EP-1863933-A2 DIMERIC AND TRIMERIC NUCLEIC ACID DYES, AND ASSOCIATED SYSTEMS AND METHODS Biotium Inc. (US) 2007-12-12 EP disclosed
US-20060211028-A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods ALLELOGIC BIOSCIENCES CORPORATION 2006-09-21 US disclosed
US-20060211029-A1 Methods of using dyes in association with nucleic acid staining or detection and associated technology BIOTIUM, INC. 2006-09-21 US disclosed
WO-2006099605-A2 DIMERIC AND TRIMERIC NUCLEIC ACID DYES, AND ASSOCIATED SYSTEMS AND METHODS BIOTIUM, INC. (US) 2006-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317016-A1 DYES AND LABELED MOLECULES DNA2, POLL, POLRMT SMN1; SMN2 3673/4885NQO2 1703/4885L3MBTL1 580/4885
US-20060211028-A1 Dimeric and trimeric nucleic acid dyes, and associated systems and methods DNA2, POLRMT, POLL SMN1; SMN2 2672/4885NQO2 2307/4885L3MBTL1 1030/4885
US-20060211029-A1 Methods of using dyes in association with nucleic acid staining or detection and associated technology HNRNPLL, HNRNPL, HNRNPH3 SMN1; SMN2 2523/4885NQO2 2280/4885L3MBTL1 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.